Publication:
Characterization of COPD Admissions During the First COVID-19 Outbreak.

dc.contributor.authorCosio, Borja G
dc.contributor.authorShafiek, Hanaa
dc.contributor.authorToledo-Pons, Nuria
dc.contributor.authorIglesias, Amanda
dc.contributor.authorBarcelo, Margalida
dc.contributor.authorRepresas-Represas, Cristina
dc.contributor.authorComeche, Lorena
dc.contributor.authorCatalan, Pablo
dc.contributor.authorFernandez-Villar, Alberto
dc.contributor.authorLopez-Campos, Jose Luis
dc.contributor.authorEchave-Sustaeta, Jose
dc.contributor.authorSoler-Cataluna, Juan Jose
dc.date.accessioned2023-02-09T11:40:22Z
dc.date.available2023-02-09T11:40:22Z
dc.date.issued2021-06-03
dc.description.abstractExacerbations of COPD (ECOPD) are a frequent cause of hospitalization that seemed to ameliorate during the COVID outbreak. We aimed to evaluate the clinical characteristics of COPD-related hospital admissions and mortality in relation to the presence of COVID-19. We conducted a case-control study of patients admitted in four teaching hospitals throughout Spain between March 15 and April 30, 2020. Hospital admissions of respiratory cause with and without PCR-proven SARS-CoV-2 infection in patients with COPD were evaluated. Baseline and episode-related clinical characteristics were analyzed. Logistic regression analysis was performed to evaluate the risk for mortality. During the study period, 2101 patients were admitted for respiratory worsening, 1200 (57.1%) with COVID-19. A total of 228 (10.8%) were admitted due to COPD worsening, of whom 52 (22.8%) tested positive for COVID-19. COPD patients with COVID-19, when compared to those without COVID-19, were more frequently males with better lung function (FEV1 postbronchodilator 71% vs 46% respectively, p Hospitalizations for ECOPD without COVID-19 were more frequent than COPD with COVID-19 during the first outbreak, but the latter were associated with higher mortality and low eosinophil counts that warrant further analysis.
dc.identifier.doi10.2147/COPD.S312493
dc.identifier.essn1178-2005
dc.identifier.pmcPMC8184145
dc.identifier.pmid34113088
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184145/pdf
dc.identifier.unpaywallURLhttps://www.dovepress.com/getfile.php?fileID=70196
dc.identifier.urihttp://hdl.handle.net/10668/17987
dc.journal.titleInternational journal of chronic obstructive pulmonary disease
dc.journal.titleabbreviationInt J Chron Obstruct Pulmon Dis
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number1549-1554
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCOPD exacerbation
dc.subjecthospitalization
dc.subjectinhaled corticosteroids
dc.subjectmortality
dc.subject.meshCOVID-19
dc.subject.meshCase-Control Studies
dc.subject.meshDisease Outbreaks
dc.subject.meshHospitalization
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshPulmonary Disease, Chronic Obstructive
dc.subject.meshSARS-CoV-2
dc.subject.meshSpain
dc.titleCharacterization of COPD Admissions During the First COVID-19 Outbreak.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number16
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC8184145.pdf
Size:
294.68 KB
Format:
Adobe Portable Document Format